JPWO2022034909A1 - - Google Patents

Info

Publication number
JPWO2022034909A1
JPWO2022034909A1 JP2022542874A JP2022542874A JPWO2022034909A1 JP WO2022034909 A1 JPWO2022034909 A1 JP WO2022034909A1 JP 2022542874 A JP2022542874 A JP 2022542874A JP 2022542874 A JP2022542874 A JP 2022542874A JP WO2022034909 A1 JPWO2022034909 A1 JP WO2022034909A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022542874A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022034909A1 publication Critical patent/JPWO2022034909A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022542874A 2020-08-13 2021-08-12 Pending JPWO2022034909A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020136796 2020-08-13
PCT/JP2021/029701 WO2022034909A1 (ja) 2020-08-13 2021-08-12 セペタプロストを含有する医薬製剤

Publications (1)

Publication Number Publication Date
JPWO2022034909A1 true JPWO2022034909A1 (cg-RX-API-DMAC7.html) 2022-02-17

Family

ID=80248014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022542874A Pending JPWO2022034909A1 (cg-RX-API-DMAC7.html) 2020-08-13 2021-08-12

Country Status (7)

Country Link
US (1) US20230285411A1 (cg-RX-API-DMAC7.html)
EP (1) EP4197540A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022034909A1 (cg-RX-API-DMAC7.html)
KR (1) KR20230051199A (cg-RX-API-DMAC7.html)
CN (1) CN115768433A (cg-RX-API-DMAC7.html)
TW (1) TW202220666A (cg-RX-API-DMAC7.html)
WO (1) WO2022034909A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202404569A (zh) 2022-04-22 2024-02-01 日商參天製藥股份有限公司 含有賽佩普斯特(Sepetaprost)之眼科用組合物
TW202517277A (zh) * 2023-10-10 2025-05-01 日商參天製藥股份有限公司 含有賽佩普斯特(Sepetaprost)之點眼液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013651A1 (ja) * 2009-07-28 2011-02-03 小野薬品工業株式会社 二環式化合物およびその医薬用途
WO2019131901A1 (ja) * 2017-12-28 2019-07-04 参天製薬株式会社 ピリジルアミノ酢酸化合物を含有する医薬製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011013651A (ja) 2009-07-03 2011-01-20 Mitsumasa Maeda フレキシブルディスプレイのれん
WO2019124489A1 (ja) * 2017-12-21 2019-06-27 参天製薬株式会社 セペタプロストとep2アゴニストとの組み合わせ医薬
EP3730138B1 (en) * 2017-12-21 2024-02-14 Santen Pharmaceutical Co., Ltd. Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
JP2022508715A (ja) * 2018-10-15 2022-01-19 オキュフィア・ファーマ・インコーポレイテッド 緑内障および関連状態の処置のための方法および組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013651A1 (ja) * 2009-07-28 2011-02-03 小野薬品工業株式会社 二環式化合物およびその医薬用途
WO2019131901A1 (ja) * 2017-12-28 2019-07-04 参天製薬株式会社 ピリジルアミノ酢酸化合物を含有する医薬製剤

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRITISH JOURNAL OF OPHTHALMOLOGY, vol. 101, JPN6025037387, 2017, pages 796 - 800, ISSN: 0005917578 *
EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 27, no. 10, JPN6026002788, 2018, pages 777 - 785, ISSN: 0005917582 *
LU LOUISE J. ET AL: "Novel Pahrmacologic Candidates for Treatment of Primary Open-Angle Glaucoma", YAEL JOURNAL OF BIOLOGY AND MEDICINE, vol. 90, JPN6025037386, 2017, pages 111 - 118, ISSN: 0005917581 *
OTA, TAKASHI ET AL.: "The Effects of Prostaglandin Analogues on Prostanoid EP1, EP2, and EP3 Receptor-Deficient Mice", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. Vol. 47, Issue 8, JPN6021035231, August 2006 (2006-08-01), pages 3395 - 3399, ISSN: 0005917577 *
YAMANE, SHINSAKU: "IOP-Lowering Effects of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkey", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. Vol. 56, Issue 4, JPN6021035234, April 2015 (2015-04-01), pages 2547 - 2552, ISSN: 0005917580 *
神戸 透 ほか: "新規緑内障治療薬を指向したEP3/FPデュアル作動薬ONO-9054の創製", MEDCHEM NEWS, vol. 第27巻第2号, JPN6021035230, 1 May 2017 (2017-05-01), pages 70 - 77, ISSN: 0005917579 *

Also Published As

Publication number Publication date
EP4197540A4 (en) 2024-06-19
KR20230051199A (ko) 2023-04-17
TW202220666A (zh) 2022-06-01
US20230285411A1 (en) 2023-09-14
WO2022034909A1 (ja) 2022-02-17
CN115768433A (zh) 2023-03-07
EP4197540A1 (en) 2023-06-21

Similar Documents

Publication Publication Date Title
BR102021007058A2 (cg-RX-API-DMAC7.html)
BR102020022030A2 (cg-RX-API-DMAC7.html)
BR102021013306B1 (pt) Disposição introduzida em forno de pizza, com dispostivo de regulagem de altura da esteira com ajustes gradual escalonado
BR102021010942B1 (pt) Dispositivo mecânico para abertura e fechamento de portas para diferentes tipos de maçaneta, bola ou alavanca, acionado por pedal
BR102021010384B1 (pt) Equipamento para limpeza e/ou teste de bicos injetores com alta pressão
BR102021009961B1 (pt) Sistema e método para aproveitamento da água de injeção dessulfatada de plataformas marítimas para utilização em squeezes de inibição
BR102021007825B1 (pt) Equipamento de entretenimento e contemplação visual por cabines rotacionais e com giro radial e axial de 360 graus, para instalação em coberturas de edificações, penhascos ou encostas de elevações geográficas abissais
BR102021006565B1 (pt) Máquina de acabamento de estradas e método para operar a mesma
BR102021005700B1 (pt) Selo irregular para redução de ruído em aeronaves
BR102021005383B1 (pt) Método de perfurar um furo de poço marítimo com circulação reversa de fluido sem uso de tubulares de riser de perfuração
BR102021004908B1 (pt) Equipamento gerador de dióxido de cloro com processamento em alta pressão em reator com três zonas de operação para tratamento de águas e efluentes
BR102021003589B1 (pt) Método para fabricar uma estrutura monolítica em formato de caixa para fuselagens e asas de aeronave usando um material prepreg de matriz de polímero reforçada com fibra
BR102021003353B1 (pt) Aerofólio compósito estrutural, aeronave e método de montagem de um aerofólio compósito estrutural
BR102021000474B1 (pt) Aparelho de pino de medição, sistema de amortecimento multiator, e, conjunto de amortecedor de impacto
BR102020026775B1 (pt) Montagem de painel de malha de arame soldado e uma ou mais armações, e parede ou teto reforçado por uma ou mais montagens
BR102020026454B1 (pt) Membrana de nanocelulose bacteriana e seu uso como bolus em radioterapia
BR102020026302B1 (pt) Processo de produção de corante natural azul
BR102020023974B1 (pt) Revestimento de amarras para redução de arrasto longitudinal
BR102020021170B1 (pt) Composição, formulações orais e uso
BR102020018864B1 (pt) Grade de ventilação modular
BR102020018483B1 (pt) Dispositivo mecânico para arraste de cabeçote móvel para realização de furos, alargamentos, roscas com machos por intermédio de automatização em tornos mecânicos horizontais
BR102020016764B1 (pt) Forma de dosagem intrauretral de medicamento; e dispositivo
BR102020013192B1 (pt) Distribuidor de fertilizante sólido para equipamentos agrícolas, e equipamento agrícola dotado de distribuidor de fertilizante sólido
BR102020010912B1 (pt) Aparelho compacto de eletrólise de baixo custo
BR102020005641B1 (pt) Método integrado de cultura do peixe lambari-do-rabo-amarelo, camarão-da-amazônia e o peixe curimbatá

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251003

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260402

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260728